India Takes Another Stab At Regulating Devices As Devices
As part of the Indian government's three-pronged strategy to bring the entire medtech sector under regulatory control, it has proposed new rules and finalized quality management system standards for medical devices and in vitro diagnostics.
You may also be interested in...
India will finally get a device-specific regulatory framework when new rules formed by the government come into force next year. While the medtech industry has welcomed this long-awaited development, it hopes that its outstanding concerns will be addressed before the rules come into play.
An end-of-year flurry of regulatory activity in the Asian medtech markets has kept industry on its toes, with initiatives in China, Taiwan and Korea, among other regions. But as Asia Regulatory Professional Association (ARPA) Secretary Jack Wong and ARQon consultant May Ng observe in this December update for Medtech Insight, governments and companies in certain markets might benefit from a little more pressure in view of the regulatory tasks they face.
Saudi Arabia has explained what information on a drug’s review will be made public following a marketing authorization decision.